U.S. Receives Latest Batch of Anthrax Vaccine

A U.S. pharmaceutical firm recently delivered 3 million doses of anthrax vaccine to the Health and Human Services Department.  The order was the latest batch in a 5 million-dose contract that is scheduled to be completed by May 31, 2007 (see GSN, May 8).

Emergent Biosolutions, the parent company of the firm once known as BioPort Corp., has supplied more than 9 million doses for the U.S. Strategic National Stockpile since 2005, according to a company release.

“We are proud to play a vital role in the strategic defense of the United States and the protection of its citizens from the threat of an anthrax attack,” said company chief Fuad El-Hibri in the release (Emergent BioSolutions release, Dec. 14).

Back to top
About Newswire  |  Contact National Journal  |  Re-Use Guidelines © Copyright 2008 by National Journal Group, Inc. The material in this section is produced independently for NTI by National Journal Group, Inc. Any reproduction or retransmission, in whole or in part, is a violation of federal law and is strictly prohibited without the consent of the National Journal Group, Inc. All rights reserved.